From GlobeNewswire: 2025-05-15 08:35:00

Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) announced $3,308,297 in revenue for Q1 2025, totaling up to $100 million in sales revenue since 2017. Key accomplishments include milestones in patients and physicians, as well as relaunching Veriheal.com and DosePop.com for their telehealth healthcare technology diversification strategy.

Veri Medtech (VRHI) relaunched Veriheal.com and DosePop.com, positioning themselves as a leading healthcare platform. CEO Sam Adetunji highlights Veri Medtech’s Infinite Wellness Loop, aiming to capture a share of the $114 billion telehealth opportunity. Veri Medtech actively explores acquisitions to enhance patient engagement across alternative medicine, longevity, and wellness science sectors.

The global telemedicine market was valued at USD 114.98 billion in 2023, with a projected CAGR of 17.96% from 2024 to 2030. Factors driving market growth include industry consolidation, strategic initiatives, rising telemedicine adoption by providers, increasing patient acceptance, and improved quality of care delivery. Walmart’s acquisition of MeMD in May 2021 is a notable example of expanding telehealth services.



Read more at GlobeNewswire:: Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone